WASATCH ADVISORS LP

Position in IMTX — Immatics N.V.

CIK 814133 SALT LAKE CITY, UT

Position in IMTX

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$4,472,496

-$101,362 QoQ

Shares Held

441,510

-5.0% QoQ

Ownership

0.323%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

of 1 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

WASATCH ADVISORS LP holds $96,311,805 across 9 Biotechnology names. IMTX ranks #7 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TARS	Tarsus Pharmaceuticals, Inc.	368,568	$23,197,669
2	CCCC	C4 Therapeutics, Inc.	3,522,644	$16,450,747
3	PHAT	Phathom Pharmaceuticals, Inc.	1,307,247	$14,183,629
4	VKTX	Viking Therapeutics, Inc.	312,767	$12,201,040
5	DYN	Dyne Therapeutics, Inc.	443,668	$9,853,866
6	MGNX	Macrogenics Inc	2,018,881	$9,327,230
7	IMTX	Immatics N.V. This page	441,510	$4,472,496
8	NKTX	Nkarta, Inc.	1,577,847	$4,465,307

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,472,496	441,510	-5.0%	Shares	Sole	2026-07-10
2026-03-31	$4,573,858	464,823	-9.8%	Shares	Sole	2026-04-21
2025-12-31	$5,408,844	515,128	-28.3%	Shares	Sole	2026-02-12
2025-09-30	$6,125,002	718,897	-8.4%	Shares	Sole	2025-11-14
2025-06-30	$4,224,128	785,154	+35.9%	Shares	Sole	2025-08-14
2025-03-31	$2,605,260	577,663	-39.6%	Shares	Sole	2025-05-15
2024-12-31	$6,804,639	957,052	+9.7%	Shares	Sole	2025-02-13
2024-09-30	$9,955,350	872,511	+3.5%	Shares	Sole	2024-11-14
2024-06-30	$9,798,820	843,272	+15.5%	Shares	Sole	2024-08-14
2024-03-31	$7,676,440	730,394	—	Shares	Sole	2024-04-18
No filing history on record for this holder in this stock.